[1] K.A. Bielefeld, S. Amini-Nik, B.A. Alman, Cutaneous wound healing: recruiting developmental pathways for regeneration, Cell Mol Life Sci 70(12) (2013) 2059-81.
[2] S. McGinty, W.J. Siddiqui, Keloid, StatPearls, Treasure Island (FL), 2020.
[3] L.J. van den Broek, G.C. Limandjaja, F.B. Niessen, S. Gibbs, Human hypertrophic and keloid scar models: principles, limitations and future challenges from a tissue engineering perspective, Exp Dermatol 23(6) (2014) 382-6.
[4] S. Ud-Din, A. Bayat, New insights on keloids, hypertrophic scars, and striae, Dermatol Clin 32(2) (2014) 193-209.
[5] A. Armour, P.G. Scott, E.E. Tredget, Cellular and molecular pathology of HTS: basis for treatment, Wound Repair Regen 15 Suppl 1 (2007) S6-17.
[6] J.P. Andrews, J. Marttala, E. Macarak, J. Rosenbloom, J. Uitto, Keloids: The paradigm of skin fibrosis - Pathomechanisms and treatment, Matrix Biol 51 (2016) 37-46.
[7] B. Berman, A. Maderal, B. Raphael, Keloids and Hypertrophic Scars: Pathophysiology, Classification, and Treatment, Dermatol Surg 43 Suppl 1 (2017) S3-S18.
[8] F. Fang, R.L. Huang, Y. Zheng, M. Liu, R. Huo, Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling, J Dermatol Sci 83(2) (2016) 95-105.
[9] F. Xie, L. Teng, J. Xu, J. Lu, C. Zhang, L. Yang, X. Ma, M. Zhao, Adipose-derived mesenchymal stem cells inhibit cell proliferation and migration and suppress extracellular matrix synthesis in hypertrophic-scar and keloid fibroblasts, Exp Ther Med 21(2) (2021) 139.
[10] T.W. Tsutsui, Dental Pulp Stem Cells: Advances to Applications, Stem Cells Cloning 13 (2020) 33-42.
[11] Y. Zhao, Y. Zheng, W. Eichhorn, J. Klatt, A. Henningsen, L. Kluwe, R.E. Friedrich, M. Gosau, R. Smeets, Enriching Stem/Progenitor Cells from Dental Pulp Cells by Low-density Culturing, In Vivo 33(1) (2019) 23-29.
[12] J. Zhang, Z. Liu, W. Cao, L. Chen, X. Xiong, S. Qin, Z. Zhang, X. Li, C.A. Hu, Amentoflavone inhibits angiogenesis of endothelial cells and stimulates apoptosis in hypertrophic scar fibroblasts, Burns 40(5) (2014) 922-9.
[13] L. He, A.G. Marneros, Macrophages are essential for the early wound healing response and the formation of a fibrovascular scar, Am J Pathol 182(6) (2013) 2407-17.
[14] P. Bernabei, L. Rigamonti, S. Ariotti, M. Stella, C. Castagnoli, F. Novelli, Functional analysis of T lymphocytes infiltrating the dermis and epidermis of post-burn hypertrophic scar tissues, Burns 25(1) (1999) 43-8.
[15] Y.F. Gong, X.M. Zhang, F. Liu, Z.Z. Wang, X.F. Deng, Y. Jiao, X.J. Li, X.Y. Huang, Inhibitory effect of recombinant human endostatin on the proliferation of hypertrophic scar fibroblasts in a rabbit ear model, Eur J Pharmacol 791 (2016) 647-654.
[16] H. Wang, Z. Chen, X. Li, Y. Tang, X. Li, S. Zhang, L. Ma, X. Huang, TSG-6 treatment promoted apoptosis in human fibroblasts of pathological scar, Cell Mol Biol (Noisy-le-grand) 62(6) (2016) 33-7.
[17] J.Q. Cao, Y.Y. Liang, Y.Q. Li, H.L. Zhang, Y.L. Zhu, J. Geng, L.Q. Yang, S.W. Feng, J. Yang, J. Kong, C. Zhang, Adipose-derived stem cells enhance myogenic differentiation in the mdx mouse model of muscular dystrophy via paracrine signaling, Neural Regen Res 11(10) (2016) 1638-1643.
[18] H.J. Harn, S.Z. Lin, S.H. Hung, Y.M. Subeq, Y.S. Li, W.S. Syu, D.C. Ding, R.P. Lee, D.K. Hsieh, P.C. Lin, T.W. Chiou, Adipose-derived stem cells can abrogate chemical-induced liver fibrosis and facilitate recovery of liver function, Cell Transplant 21(12) (2012) 2753-64.
[19] C. Zhang, T. Wang, L. Zhang, P. Chen, S. Tang, A. Chen, M. Li, G. Peng, H. Gao, H. Weng, H. Zhang, S. Li, J. Chen, L. Chen, X. Chen, Combination of lyophilized adipose-derived stem cell concentrated conditioned medium and polysaccharide hydrogel in the inhibition of hypertrophic scarring, Stem Cell Res Ther 12(1) (2021) 23.
[20] J. Zhao, B. Shu, L. Chen, J. Tang, L. Zhang, J. Xie, X. Liu, Y. Xu, S. Qi, Prostaglandin E2 inhibits collagen synthesis in dermal fibroblasts and prevents hypertrophic scar formation in vivo, Exp Dermatol 25(8) (2016) 604-10.
[21] S. Tejiram, J. Zhang, T.E. Travis, B.C. Carney, A. Alkhalil, L.T. Moffatt, L.S. Johnson, J.W. Shupp, Compression therapy affects collagen type balance in hypertrophic scar, J Surg Res 201(2) (2016) 299-305.
[22] S.Y. Song, J.E. Jung, Y.R. Jeon, K.C. Tark, D.H. Lew, Determination of adipose-derived stem cell application on photo-aged fibroblasts, based on paracrine function, Cytotherapy 13(3) (2011) 378-84.
[23] G.A. Abusin, R.F. Abu-Arja, R.D. Gingrich, M.D. Silverman, G.K. Zamba, A.J. Schlueter, An algorithm for utilizing peripheral blood CD34 count as a predictor of the need for plerixafor in autologous stem cell mobilization--cost-effectiveness analysis, J Clin Apher 28(4) (2013) 293-300.
[24] Q. Chun, W. ZhiYong, S. Fei, W. XiQiao, Dynamic biological changes in fibroblasts during hypertrophic scar formation and regression, Int Wound J 13(2) (2016) 257-62.
[25] Z.B. Kryger, M. Sisco, N.K. Roy, L. Lu, D. Rosenberg, T.A. Mustoe, Temporal expression of the transforming growth factor-Beta pathway in the rabbit ear model of wound healing and scarring, J Am Coll Surg 205(1) (2007) 78-88.
[26] W. Chen, X. Fu, S. Ge, T. Sun, G. Zhou, D. Jiang, Z. Sheng, Ontogeny of expression of transforming growth factor-beta and its receptors and their possible relationship with scarless healing in human fetal skin, Wound Repair Regen 13(1) (2005) 68-75.
[27] C.H. Lee, B. Shah, E.K. Moioli, J.J. Mao, CTGF directs fibroblast differentiation from human mesenchymal stem/stromal cells and defines connective tissue healing in a rodent injury model, J Clin Invest 120(9) (2010) 3340-9.
[28] D. Abraham, Connective tissue growth factor: growth factor, matricellular organizer, fibrotic biomarker or molecular target for anti-fibrotic therapy in SSc?, Rheumatology (Oxford) 47 Suppl 5 (2008) v8-9.
[29] K.J. Ashcroft, F. Syed, A. Bayat, Site-specific keloid fibroblasts alter the behaviour of normal skin and normal scar fibroblasts through paracrine signalling, PLoS One 8(12) (2013) e75600.
[30] N. Murao, K. Seino, T. Hayashi, M. Ikeda, E. Funayama, H. Furukawa, Y. Yamamoto, A. Oyama, Treg-enriched CD4+ T cells attenuate collagen synthesis in keloid fibroblasts, Exp Dermatol 23(4) (2014) 266-71.
[31] A. Mukhopadhyay, M.Y. Wong, S.Y. Chan, D.V. Do, A. Khoo, C.T. Ong, H.H. Cheong, I.J. Lim, T.T. Phan, Syndecan-2 and decorin: proteoglycans with a difference--implications in keloid pathogenesis, J Trauma 68(4) (2010) 999-1008.